Xeltis Peripheral Artery Disease (XPAD) Bypass Conduit Early Feasibility Study

NARecruitingINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

May 2, 2025

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2028

Conditions
Peripheral Artery Occlusive Disease
Interventions
DEVICE

Xeltis Peripheral Artery Disease (XPAD) Bypass Conduit

The XPAD bypass conduit is a sterile, restorative biodegradable polymer-based vascular graft, consisting of a tubular structure with a 33cm length and 6mm inner diameter. It is comprised of a highly porous polymer matrix and an embedded electropolished nitinol reinforcement layer (Strain Relief System). The XPAD conduit is in a straight configuration and may be implanted above the knee for elective femoral popliteal bypass surgery.

Trial Locations (1)

Unknown

RECRUITING

Centro de Investigación y Manejo del Cáncer (CIMCA), San José

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Xeltis

INDUSTRY